4//SEC Filing
Danahy Kevin Patrick 4
Accession 0001437749-24-022356
CIK 0001625101other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 9:12 AM ET
Size
9.5 KB
Accession
0001437749-24-022356
Insider Transaction Report
Form 4
Danahy Kevin Patrick
Chief Commercial Officer
Transactions
- Exercise of In-Money
Common Stock
2024-07-03+650→ 36,537 total - Purchase
Warrant (right to buy)
2024-07-03+325→ 325 totalExercise: $11.00From: 2024-07-03Exp: 2029-07-03→ Common Stock (325 underlying) - Purchase
Warrant (right to buy)
2024-07-03+325→ 325 totalExercise: $11.00From: 2024-07-03Exp: 2029-07-03→ Common Stock (325 underlying)
Footnotes (2)
- [F1]The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
- [F2]Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
Documents
Issuer
PULSE BIOSCIENCES, INC.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001913245
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 9:12 AM ET
- Size
- 9.5 KB